References
- Berenguer J, Allende MC, Lee JW, et al. Pathogenesis of pulmonary aspergillosis granulocytopenia vs cyclosporine and methylprednisone-induced immunosuppression. Am J Respir Crit Care Med 1995; 152: 1079–1086
- Meersseman W, Vandecasteele SJ, Wilmer A, et al. Invasive aspergillosis in critically ill patients without malignancies. Am J Respir Crit Care Med 2004; 170: 621–625
- Lionakis MS, Kontoyiannis DP. Glucocorticoids and invasive fungal infections. Lancet 2003; 362: 1828–1838
- Wiest PM, Flanigan T, Salata RA, et al. Serious complications of corticosteroid therapy for COPD. Chest 1989; 95: 1180–1184
- Palmer LB, Greenberg HE, Schiff MJ. Corticosteroid treatment as a risk factor for invasive aspergillosis in patients with lung disease. Thorax 1991; 46: 15–20
- Conesa D, Rello J, Valles J, et al. Invasive aspergillosis: a life-threatening complication of short-term steroid treatment. Ann Pharmacother 1995; 29: 1235–1237
- Agustí C, Rañó A, Filella X, et al. Pulmonary infiltrates in patients receiving long-term glucocorticoid treatment: etiology, prognostic factors, and associated inflammatory response. Chest 2003; 123: 488–498
- Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplant: an international consensus. Clin Infect Dis 2002; 34: 7–14
- Ader F, Nseir S, Le Berre R, et al. Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen. Clin Microbiol Infect 2005; 11: 427–429
- Bulpa PA, Dive AM, Garrino MG, et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care. Intensive Care Med 2001; 27: 59–67
- Rello J, Esandi ME, Mariscal D, et al. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis 1998; 26: 1473
- Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticoids. Rev Infect Dis 1989; 69: 954–963
- Rodrigues J, Niederman M, Fein A, et al. Nonresolving pneumonia in steroid-treated patients with obstructive lung disease. Am J Med 1992; 93: 29–34
- Leav BA, Fanburg B, Hadley S. Invasive pulmonary aspergillosis associated with high-dose inhaled fluticasone. N Engl J Med 2000; 343: 586
- Garnacho J, Amaya R, Ortiz C, et al. Isolation of Aspergillus spp from the respiratory tract in critically ill patients: risk factors, clinical presentation and outcome. Crit Care 2005; 9: 91–199
- Gefter WB, Albelda SM, Talbot GH, et al. Invasive pulmonary aspergillosis and acute leukemia: limitations in the diagnostic utility of the air crescent sing. Radiology 1985; 157: 605–610
- Perfect JR, Cox GM, Lee JY, et al. Mycoses Study Group. The impact of culture isolation of Aspergillus species: a hospital-based survey of Aspergillosis. Clin infect Dis 2001; 33: 1824–1833
- Denning DW. Aspergillosis in ‘nonimmunocompromised' critically ill patients. Am J Respir Crit Care Med 2004; 170: 580–581